Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor (4P)
This study has been terminated.
Sponsor:
begoña Martinez de Tejada
Collaborators:
Centre Hospitalier Universitaire Vaudois
University Hospital Inselspital, Berne
Basel Women’s University Hospital
University of Zurich
Kantonsspital Chur
Cantonal Hospital of St. Gallen
Luzerner Kantonsspital
Kantonsspital Winterthur KSW
Besins Laboratory, Belgium
Hospital Bernardino Rivadavia Buenos Aires
Hospital Carlos G. Durand Buenos Aires
CEMIC Buenos Aires
Hospital Donación Francisco Santojanni Buenos Aires
Hospital Dr. Cosme Argerich Buenos Aires
Hospital Dr. T. Alvarez Buenos Aires
Hospital Italiano de Buenos Aires
Hospital J. M. Penna Buenos Aires
Hospital Materno Infantil Ramón Sardá Buenos Aires
Hospital Interzonal Alberto Antranik Eurnekian, provincia Buenos Aires
Hospital Municipal Materno Infantil Comodoro Hugo Cesar Meisner, provincia Buenos Aires
Hospital Comunal de Tigre, provincia Buenos Aires
Hospital Dr. Arturo Oñativia, provincia Buenos Aires
Hospital Dr. Carlos Bocalandro, provincia Buenos Aires
Hospital Héroes de Malvinas, provincia Buenos Aires
Hospital Magdalena V. de Martínez, provincia Buenos Aires
Hospital Mariano y Luciano de la Vega, provincia Buenos Aires
Hospital Municipal Ostaciana B. de Lavignolle, provincia Buenos Aires
Hospital Materno Infantil de San Isidro, provincia Buenos Aires
Hospital Virgen del Carmen, provincia Buenos Aires
Hospital J. B. Iturraspe, Santa Fe
Hospital Maternidad Nuestra Señora De Las Mercedes, Tucumán
Hospital Materno Infantil San Roque, Entre Ríos
Hospital Villa Dolores, Córdoba
Information provided by (Responsible Party):
begoña Martinez de Tejada, University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT00536003
First received: September 24, 2007
Last updated: June 5, 2012
Last verified: June 2012
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | September 24, 2007 | ||||
| Last Updated Date | June 5, 2012 | ||||
| Start Date ICMJE | July 2006 | ||||
| Estimated Primary Completion Date | December 2012 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
The principal aim is to demonstrate that progesterone reduces preterm birth before 37 weeks of gestation [ Time Frame: end of pregnancy ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE |
The principal aim is to demonstrate that progesterone reduces preterm birth before 37 weeks of gestation [ Time Frame: end of pregnancy ] | ||||
| Change History | Complete list of historical versions of study NCT00536003 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
Secondary aims are to show that progesterone 1) reduces preterm birth before 32 and before 34 weeks of gestation 2) reduces the number and duration of recurring episodes of preterm labor and 3) reduces perinatal mortality and morbidity, 4)Side effects [ Time Frame: end of pregnancy and 28 days after delivery ] [ Designated as safety issue: Yes ] | ||||
| Original Secondary Outcome Measures ICMJE |
Secondary aims are to show that progesterone 1) reduces preterm birth before 32 and before 34 weeks of gestation 2) reduces the number and duration of recurring episodes of preterm labor and 3) reduces perinatal mortality and morbidity. [ Time Frame: end of pregnancy and 28 days after delivery ] | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor | ||||
| Official Title ICMJE | Prevention of Preterm Delivery With Vaginal Progesterone in Women With Preterm Labor | ||||
| Brief Summary | The administration of vaginal progesterone, in addition to standard tocolysis, will decrease the risk of delivering prematurely and of recurrent preterm labor. We also hypothesize that the reduction in preterm delivery will be associated with a decrease in infant mortality and morbidity. |
||||
| Detailed Description | The principal aim is to demonstrate that progesterone reduces preterm birth before 37 weeks of gestation. Secondary aims are to show that progesterone 1) reduces preterm birth before 32 and before 34 weeks of gestation 2) reduces the number and duration of recurring episodes of preterm labor and 3) reduces infant mortality and morbidity. |
||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Phase 3 | ||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Prevention |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE |
|
||||
| Study Arm (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Terminated | ||||
| Enrollment ICMJE | 384 | ||||
| Estimated Completion Date | December 2012 | ||||
| Estimated Primary Completion Date | December 2012 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Female | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | Argentina, Switzerland | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00536003 | ||||
| Other Study ID Numbers ICMJE | CER: 04-196, matped 04-001 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | begoña Martinez de Tejada, University Hospital, Geneva | ||||
| Study Sponsor ICMJE | begoña Martinez de Tejada | ||||
| Collaborators ICMJE |
|
||||
| Investigators ICMJE |
|
||||
| Information Provided By | University Hospital, Geneva | ||||
| Verification Date | June 2012 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||